Keep pace with the market alphawork continuously evaluates incoming information against your theses and screens, works through what matters and keeps the underlying analysis current.
Sonora Co Continuous monitoring1 event added
Sep-02 Sonora Co CFO to speak at conference Sep-10 Event added
Aug-01 Monterrey Co cut price by 10% Update to review
FY27F subscribers 22.2m 21.4m, revenue growth 8% 5%
1 perspective added 1 context · 1 perspective added
Jul-28 Sonora Co announces local sports sponsorship Not material
Jul-17 Sonora Co names new SVP marketing Context added
Jul-15 Goldman Sachs: Customers pay up for network quality Perspective added
Jul-14 Q2 earnings Update accepted
FY27F subscribers 21.6m 22.2m, revenue growth 7% 8%
Every development assessed through your lens Sonora Co(4.0%) · Monterrey’s price cut puts Sonora’s premium growth thesis at risk
How is this relevant? 8% revenue growth at risk Price difference 20% 33%
What were the expectations? No analyst modeled the event. Shares −10%, imply a surprise.
What are the scenarios? Plan price 0% −5% −10% Subs −4% −2% 0% Rev growth 5% 2% −2%
What does it mean for returns? Plan price 0% −5% −10% Valuation ($) 56 51 44 Return +12% +2% −12%
Implications traced across your coverage Business relationships Monterrey Co cut price by 10%
Sonora Co (4.0%) Competitor
FY27F growth 8% 5%
Macro exposures Oil price up 15%
Calder Chemicals (3.2%)
Unhedged, margin −1.5pp at current level
Northwind Airlines
Hedged, limited long-term impact
Industry themes AI infrastructure capex
Cascade Networks (2.5%)
Data centers are 35% of revenue
Kestrel Power (2.2%)
20% of contracted demand
Models that follow through in detail alphawork carries new evidence through detailed operating drivers, forecasts and comparable valuations behind your investments.
Calder Chemicals Revenue Costs P&L Comps Valuation
$M FY25A FY26F FY27F
Base chemicals
Polymers
Specialty chemicals
Total revenue
Growth
FY27F ($M) Previous Updated Base chemicals 1,800 1,908 Polymers 1,350 1,404 Specialty chemicals 850 850
Calder Chemicals Revenue Costs P&L Comps Valuation
FY27F Price ($) EV / EBIT P/E Leverage
Calder Chemicals 14.20 10.3x 12.0x 2.1x
Holt Chemicals 31.60 9.2x 11.4x 1.6x
Ridge Polymers 18.75 11.0x 13.8x 2.4x
Peer median – 10.1x 12.6x 2.0x
Sources
Calder Chemicals Your forecast Updated Oct-28 Holt Chemicals Consensus Updated Oct-30 Ridge Polymers Consensus Updated Nov-05
New opportunities drafted as they emerge alphawork runs your screens as information emerges, performs the initial research and brings the relevant opportunities forward.
Screens triggered
Screen Profitability improvement
Ostrel Dental : growing patients, high staff costsCiti · Aug-22
Screen M&A events
Larks Logistics exploring a potential saleCNBC · Aug-21
Ostrel Dental Drafted
Fundamentals
Dental clinic network, 240 practices, recently listed. 12% EBIT margin vs 19% for Marbury Dental. Opportunity
Centralize scheduling and buying to close margin gap.